SMN, the Product of the Spinal Muscular Atrophy Gene, Binds Preferentially to Dimethylarginine-Containing Protein Targets
Year: 2001
Type: article
Source: Molecular Cell
Institutions: Howard Hughes Medical Institute, University of Pennsylvania
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W1978550291
